Sherry AW

RNA in Disease and Technologies
PhD – Developmental Biology, Harvard, USA

SUMMARY
Sherry Aw is a Principal Investigator at the Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR) . 

Sherry started as an Independent Fellow at IMCB in 2017, before becoming a Principal Investigator at IMCB in 2021. She develops RNA technologies for diagnostic, therapeutic and other translational applications.

Sherry obtained her Bachelor of Science in Biochemistry at the University of Wisconsin-Madison, USA, and her PhD in Developmental Biology at Harvard University, USA.

Sherry is a recipient of scholarships from the Singapore Economic Development Board and A*STAR. She is also a co-inventor on four patents, and was awarded the L'Oréal-UNESCO Singapore For Women in Science National Fellowship in Life Sciences (2017), and the L'Oréal-UNESCO For Women in Science International Fellowship (2019).

AWARDS & GRANTS

KEY AWARDS
  • 2020: Asian Scientist 100
  • 2019: L'Oréal-UNESCO For Women in Science International Fellowship International Rising Talent
  • 2017: L'Oréal-UNESCO Singapore For Women in Science National Fellowship in Life Sciences gramme
KEY GRANTS
  • 2026: National Research Foundation Competitive Research Grant (Lead PI)
  • 2025: A*STAR Cell and Gene Therapy Flagship Seed Grant C253623010 (Lead PI)
  • 2025: A*STAR Cell and Gene Therapy Flagship Seed Grant C253623008 (Lead PI)
  • 2023: A*STAR Innovation & Enterprise (I&E) GAP Award (Lead PI)
  • 2021: National Medical Research Council, Open Fund – Individual Research Grant (NMRC-OF-IRG) (Lead PI)
  • 2021: A*STAR Central Research Fund (CRF), Use-Inspired Basic Research (UIBR) Award (Lead PI)
  • 2021: Industry Alignment Fund – Pre-Positioning (IAF-PP) Award (Team PI)

RESEARCH

We are molecular engineers who utilise RNA as building blocks to develop translational technologies for disease diagnosis, biotechnology and therapeutics.

To do this, we take a cross-disciplinary approach, combining RNA biology, genetics, biochemistry and computational analysis, collaborating closely with other molecular biologists, computer scientists, chemists, and neuroscientists.

PUBLICATIONS
PATENTS
  • A ribozyme comprising a target-binding domain (SG11202111264TB)
    The present application discloses a ribozyme comprising a target-binding domain which is for binding of a target RNA molecule. The ribozyme further comprises one or more catalytic domains and one or more releasable RNA segments flanked by two ribozyme cleavage sites, wherein activation of the catalytic domains by a target RNA molecule causes the cleavage at the ribozyme cleavage sites, causing the releasable RNA segment to be released from the ribozyme. The present application further discloses the use of such ribozymes for detecting the presence of a target RNA molecule or the amplification of a target RNA molecule.

  • A simple one-step real-time molecular sensor for microRNA detection (US11174505B2)
    The present application discloses an isolated nucleic acid sequence for detecting the presence of a target nucleic acid sequence, a ribozyme for detecting the presence of a target nucleic acid sequence and uses thereof.